Hepatobiliary pathology

Current Opinion in Gastroenterology

Volumn 27, Issue 3, 2011, Pages 248-255

  Taylor, Shari L ^a   Haque, Salima ^a  

^a CARIS LIFE SCIENCES   (United States)

Author keywords

autoimmune liver disease; hemophagocytic lymphohistiocytosis; hepatocellular carcinoma; liver pathology; nonalcoholic fatty liver disease; plasma cell hepatit

Indexed keywords

ARGINASE 1; CD68 ANTIGEN; CYTOKERATIN 7; IMMUNOGLOBULIN G4; INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3;

ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT; CHILD; CLINICAL FEATURE; CYTOPENIA; ERYTHROPHAGOCYTOSIS; GENE EXPRESSION; GENE MUTATION; GRAFT DYSFUNCTION; GRAFT REJECTION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATIC ARTERY; HEPATITIS; HEPATITIS C; HEPATOBILIARY SYSTEM; HISTOPATHOLOGY; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOFIBRINOGENEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER BIOPSY; LIVER CELL; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; PLASMA CELL; PORTAL VEIN; PRIMARY SCLEROSING CHOLANGITIS; RASH; SPLENOMEGALY; TREATMENT DURATION; VIRUS HEPATITIS;

BILIARY TRACT; BILIARY TRACT DISEASES; HUMANS; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION;

EID: 79955075609     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3283457d43     Document Type: Article

References (43)

1. Pockros PJ, Hamzeh FM, Martin P, et al. Histologic outcomes in hepatitis C-infected patients with varying degrees of virologic response to interferonbased treatments. Hepatology 2010; 52:1193-1200.
2. Poynard T, McHutchison J, MannsM, et al. Impact of pegylated interferon alfa- 2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002; 122:1303-1313. (Pubitemid 34465173)
3. Neil DAH, Hübscher SG. Current views on rejection pathology in liver transplantation. Transplant Int 2010; 23:971-983.
4. Haga H, Egawa H, Fujimoto Y, et al. Acute humoral rejection and C4d immunostaining in ABO blood type incompatible liver transplantation. Liver Transpl 2006; 12:457-464.
5. Sakashita H, Haga H, Ashihara E, et al. Significance of C4d staining in ABOidentical/ compatible liver transplantation. Mod Pathol 2007; 20:676-684. (Pubitemid 46788874)
6. Schmeding M, Dankof A, Krenn V, et al. C4d in acute rejection after liver transplantation: a valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant 2006; 6:523-530. (Pubitemid 43382138)
7. Hadaya K, Ferrari-Lacraz S, Giostra E, et al. Humoral and cellular rejection after combined liver-kidney transplantation in low immunologic risk recipients. Transpl Int 2009; 22:242-246.
8. Khettry U, Huang WY, Simpson MA, et al. Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients. Hum Pathol 2007; 38:443-452. (Pubitemid 46227528)
9. Tan CK, Sian Ho JM. Concurrent de novo autoimmune hepatitis and recurrence of primary biliary cirrhosis postliver transplantation. Liver Transpl 2001; 7:461-465. (Pubitemid 32492586)
10. Fiel MI, Agarwal K, Stanca C, et al. Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl 2008; 14:861-871. (Pubitemid 351895516)
11. Ward SC, Schiano TD, Thung SN, Fiel M. Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant. Liver Transplant 2009; 15:1826-1833.
12. Schmeding M, Sauer I, Hartwig K, et al. Aging of the liver graft and functional quality in the absence of recurrent disease: a 10-year histological follow-up. Ann Transplant 2010; 15:5-13.
13. Jonas S, Al-Abadi H, Benckert C, et al. Prognostic significance of the DNAindex in liver transplantation for hepatocellular carcinoma in cirrhosis. Ann Surg 2009; 250:1008-1013.
14. Jakate S, Yabes A, Giusto D, et al. Diffuse cirrhosis-like hepatocellular carcinoma: a clinically and radiographically undetected variant mimicking cirrhosis. Am J Surg Pathol 2010; 34:935-941.
15. Salomao M, Yu WM, Brown RS Jr, et al. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. Am J Surg Pathol 2010; 34:1630-1636.
16. Ogata S, Horio T, Sugiura Y. Sarcoidosis-associated hepatocellular carcinoma. Acta Med Okayama 2010; 64:407-410.
17. Jain D, Nayak N, Saigal S. Hepatocellular carcinoma arising in association with von-Meyenburg's complexes: an incidental finding or precursor lesions? A clinicopathologic study of 4 cases. Ann of Diag Pathol 2010; 14:317-320.
18. Liu S, Chan KW, Wang B, Qiao L. Fibrolamellar hepatocellular carcinoma. Am J Gastroenterol 2009; 104:2617-2624.
19. Ward SC, Huang J, Tickoo SK, et al. Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation. Mod Pathol 2010; 23:1180-1190.
20. Ross HM, Daniel HD, Vivekanandan P, et al. Fibrolamellar carcinomas are positive for CD68. Mod Pathol 2010; 24:390-395.
21. Yan BC, Gong C, Song J, et al. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms. Am J Surg Pathol 2010; 34:1147-1154.
22. Mamiya T, Yamazaki K, Masugi Y, et al. Reduced transforming growth factorbeta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. Lab Invest 2010; 90:1339-1345.
23. Henter JI, Horne A, Aricó M, et al. Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48:124-131. (Pubitemid 44958267)
24. Chen JH, Fleming MD, Pinkus GS, et al. Pathology of the liver in familial hemophagocytic lymphohistiocytosis. Am J Surg Pathol 2010; 34:852-867.
25. Katabi N. Neoplasia of gallbladder and biliary epithelium. Arch Pathol LabMed 2010; 134:1621-1627.
26. Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118:1388-1393. (Pubitemid 46393782)
27. Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 2005; 42:641-649. (Pubitemid 41233657)
28. Carter-Kent C, Yerian LM, Brunt EM, et al. Nonalcoholic steatohepatitis in children: a multicenter clinicopathologic study. Hepatology 2009; 50:1113-1120.
29. Ko JS, Yoon JM, Yang HR, et al. Clinical and histologic features of nonalcoholic fatty liver disease in children. Dig Dis Sci 2009; 54:2225-2230.
30. Patton HM, Yates K, Unalp-Arida A, et al. Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease. Am J Gastroenterol 2010; 105:2093-2102.
31. Brunt EM, Ramrakhiani S, Cordes BG, et al. Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease. Mod Pathol 2003; 16:49-56. (Pubitemid 36152686)
32. Brunt EM, Clouston AD. Histologic features of fatty liver disease. In: Bataller R, Caballeria J, editors. Nonalcoholic steatohepatitis (NASH). Barcelona: Permanyer; 2007. pp. 95-110.
33. Rakha EA, Adamson L, Bell E, et al. Portal inflammation is associated with advanced histological changes in alcoholic and nonalcoholic fatty liver disease. J Clin Pathol 2010; 63:790-795.
34. Brunt EM, Kleiner DE, Wilson LA, et al. Portal chronic inflammation in nonalcoholic fatty liver disease: an histologic marker of advanced NAFLD clinicopathologic correlations from the NASH clinical research network. Hepatology 2009; 49:809-820.
35. Kamisawa T. IgG4-positive plasma cells specifically infiltrate various organs in autoimmune pancreatitis. Pancreas 2004; 29:167-168. (Pubitemid 38971809)
36. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathologic entity of IgG4-related autoimmune disease. J Gastroenterol 2003; 38:982-984. (Pubitemid 37455786)
37. Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007; 20:23-28. (Pubitemid 44967946)
38. Umemura T, Zen Y, Hamano H, et al. IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis. Gut 2007; 56:1471-1472. (Pubitemid 47517847)
39. Umemura T, Zen Y, Hamano H, et al. Immunoglobulin G4-hepatopathy: association of immunoglobulin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 2007; 46:463-471. (Pubitemid 47344782)
40. Deshpande V, Sainani NI, Chung RT, et al. IgG4-associated cholangitis: a comparative histologic and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material. Mod Pathol 2009; 22:1287-1295.
41. Chung H, Watanabe T, Kudo M, et al. Identification and characterization of IgG4-associated autoimmune hepatitis. Liver Int 2010; 30:222-231.
42. Moreira RK, Revetta F, Koehler E, Washington MK. Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease. World J Gastroenterol 2010; 16:453-457.
43. Cabibi D, Tarantino G, Barbaria F, et al. Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases. Dig Liv Dis 2010; 42:585-592.